FCHI8,072.13-0.39%
GDAXI23,954.56-0.27%
DJI48,861.81-0.57%
XLE58.90-0.22%
STOXX50E5,816.48-0.34%
XLF51.67-0.48%
FTSE10,213.11-1.16%
IXIC24,673.240.04%
RUT2,739.47-0.60%
GSPC7,135.95-0.04%
Temp27.3°C
UV0
Feels30.5°C
Humidity84%
Wind17.6 km/h
Air QualityAQI 1
Cloud Cover25%
Rain86%
Sunrise05:58 AM
Sunset06:47 PM
Time9:46 PM
Markets
13F
Insiders
Press Releases
Companies
People
Cayman Journal
29 April 2026
13F HOLDINGS REPORT

Mayo Clinic

Quarter ended Q2 2023 · Filed May 5, 2023 · Accession 0000950123-23-003812

Total Value
$121.8M
Positions
13
Other Managers
0
Confidential Omitted
No
View on SEC.gov

Holdings (13)

#IssuerTicker / CUSIPSharesValue% of Filing
1MSCI ACWI ETF4642882571,146,396$104.5M85.77%
2BLACK STONE MINERALSBSMLP643,617$10.1M8.29%
3Zentalis Pharmaceuticals IncZNTL297,143$5.1M4.19%
4Exact Sciences30063P1055,151$349,2890.29%
5Scilex Holding CoSCLXW42,303$346,8850.28%
6Miromatrix Med Inc60471P108191,622$321,9250.26%
7Clearpoint Neuro IncCLPT38,114$321,6820.26%
8Neuroone Medical Technologies64130M209181,754$292,6240.24%
9UNITY BIOTECHNOLOGY INCUNTCW157,198$256,2330.21%
10BIOSIG TECH INC09073N201100,891$115,0160.09%
11EVELO BIOSCIENCES INCEVEX-WT479,242$86,5990.07%
12Teladoc Health Inc ComTDOC659$17,0680.01%
13Vyant Bio Inc92942V20827,742$16,0900.01%